key: cord-0712047-ialcpb27
authors: Chen, Reuben J; Gillespie, Carla; Jassal, Karishma; Lee, James C; Read, Matthew
title: Delayed presentation of breast necrotising fasciitis due to COVID‐19 anxiety
date: 2020-06-13
journal: ANZ J Surg
DOI: 10.1111/ans.16102
sha: 50b59712f5f9a6ae90d5004f2775581b305d1517
doc_id: 712047
cord_uid: ialcpb27

nan

applied with a planned re-look in 24 hours. She remained intubated and was transferred to the intensive care unit. Upon return to theatre, the necrosis had extended into the axilla and a further debridement was performed. The patient was kept intubated and transferred to another tertiary centre to receive hyperbaric oxygen therapy. Two cycles were received in total. On day five after her initial mastectomy, the wound conditions were favourable and was repaired with primary closure (Fig 3) . She was successfully extubated, weaned off inotropic support and her renal function returned to baseline. She recovered well on the ward with ongoing intravenous antibiotics, drain tube management and allied health input.

Histopathological assessment confirmed the diagnosis of necrotising fasciitis within the resected tissue. Of note, there was no evidence of vasculitis in the breast. Tissue cultures revealed Staphylococcus hemolyticus, Peptinipholus, Enterococcus faecalis and Candida albicans.

Necrotizing fasciitis is a rare condition characterized by widespread necrosis of subcutaneous tissue and fascial planes with significant systemic toxicity. It is associated with an average mortality of 20.6% and is a surgical emergency. [1] Predisposing factors include immunosuppression, diabetes mellitus, peripheral vascular disease, and malnutrition.

Trauma, surgery, burns or soft tissue infections are common aetiologies for necrotising fasciitis. [2] Early signs of necrotising fasciitis include cellulitis and pyrexia; whereas systemic sepsis, blistering, or crepitus manifest later with progressive disease. Whilst necrotizing fasciitis can occur anywhere, common sites include the perineum, lower extremities and postoperative wounds. [3] In contrast, necrotising fasciitis of the breast is extremely rare, with only 13 cases described in literature. [4] Given the rarity of this condition, prompt diagnosis is hindered by mimickers such as mastitis, abscess and inflammatory breast malignancies. [5, 6] Depending on the extent of the disease, various surgical treatments for breast necrotizing fasciitis have been described including debridement and skin graft, quandrantectomy, nipple conserving debridement, and radical mastectomy. [7] [8] [9] In a report by Alshareef et al., bilateral mastectomies were done for involvement of both breasts. [6] Accepted Article With this rare condition, this case highlights the collateral healthcare issues brought upon by the COVID-19 pandemic. A delay in presentation due to lockdown orders resulted in clinical progression to an end-stage, critical condition requiring radical medical and surgical measures. The full ramifications of the virus on our economy, healthcare and livelihoods will not be known until long after the pandemic is over. However, it is highly likely that the viral pandemic will potentiate significant non-COVID-19 morbidity and mortality. Figure 1 . Intraoperative photograph. Necrotic subcutaneous tissue on initial incision. 

Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis

Necrotising fasciitis

Necrotising fasciitis

Necrotising fasciitis of the breast: A rare but deadly disease

Necrotizing infection of the breast mimicking carcinoma

Necrotizing Fasciitis of the Breast: Case Report with Literature Review

Primary Necrotizing Fasciitis of the Breast in an Untreated Patient with Diabetes

First report of a necrotising fasciitis of the breast following a core needle biopsy